Serif Biomedicines
Develops modified-DNA genetic medicines for treating and preventing disease
Highlights
- New on EvolcAdded 2026-10-29
About Serif Biomedicines
Serif Biomedicines develops genetic medicines using modified DNA, with technology designed to program how nucleic acids behave in the body.
Its research and development work focuses on creating DNA-based therapies for disease treatment and prevention. The team includes scientists and engineers working in nucleic acid discovery, development, and delivery.
Serif is based in Cambridge, Massachusetts, and is associated with Flagship Pioneering. Current openings include roles in analytical development, laboratory operations, and bioanalytical assays.
Product: Modified-DNA genetic medicines and the biotechnology platform used to develop them.
Jobs at Serif Biomedicines
Open roles at Serif Biomedicines in the Americas (4)
United States 4. From Serif Biomedicines's careers page or applicant tracking system; each role links to the employer.
- Senior Scientist, LNP Formulations · Cambridge, United States
- Scientist, In Vivo Pharmacology · Cambridge, United States
- Laboratory Operations Associate · Cambridge, United States
- Associate Scientist, Bioanalytical Assays · Cambridge, United States
Leadership
- Eric Keen · Principal, Flagship PioneeringSource: company website
- Louisa Helms · Principal, Flagship PioneeringSource: company website
- Noubar Afeyan · Founder and CEO, Flagship PioneeringSource: company website
- Andy Oh · Chief Financial OfficerSource: company website
More biotech & pharma companies
Simtra BioPharma Solutions
Contract development and manufacturing of sterile injectable medicines for pharmaceutical and biopharmaceutical companiesSingular Genomics
Spatial multiomics platform and tissue-analysis services for cancer and translational research labsNew on EvolcSpear Bio
Ultra-sensitive protein biomarker immunoassay kits and testing services for neuroscience researchers and cliniciansRemote-friendlyTessera Therapeutics
Genome engineering and genetic medicine development for patients with serious diseasesNew on EvolcTonix Pharmaceuticals
Develops investigational medicines and vaccines for patients with chronic conditions, infectious diseases and rare disordersNew on EvolcVaxcyte
Clinical-stage vaccine developer making pneumococcal, Group A Strep and Shigella vaccines for children and at-risk adultsRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- bunny.netMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Frontend frameworks
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- GreenhouseMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.